Interní Med. 2004; 6(5): 275-277

Paraneoplastická leukocytóza

Ladislav Slováček1,2, prof. MUDr. Ladislav Jebavý CSc3,4, prof. MUDr. Jaroslav Kačerovský DrSc4
1 Klinika onkologie a radioterapie FN a LF UK Hradec Králové
2 Univerzita obrany, Fakulta vojenského zdravotnictví, katedra válečného vnitřního lékařství, Hradec Králové
3 II. interní klinika, odd. klinické hematologie FN Hradec Králové
4 Katedra válečného vnitřního lékařství VLA J. E. Purkyně, Hradec Králové

Published: December 31, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Slováček L, Jebavý L, Kačerovský J. Paraneoplastická leukocytóza. Interní Med. 2004;6(5):275-277.

Autoři prezentují v kazuistice pacienta s paraneoplastickou leukocytózou a diferenciálně diagnostický přístup k této problematice.

Download citation

References

  1. Anděl M, Gregor P, Horák J, Kment M, Widimský P. Vnitřní lékařství, díl IIIb - Hematologie. Praha: Galén 2001: 123-124.
  2. Carmen PE, Manzullo E, Gollamudi SV, Bonin SR. Oncologic Emergencies and Paraneoplastic syndromes. Cancer Managment: A Multidisciplinary Approach. Fifth Edition (2001).
  3. Dienstbier Z, Skala E. Nádorová diagnostika pro lékaře v praxi. Praha: Grada 1995; 112-113.
  4. Green RJ, Schuchter LM. Paraneoplastic syndromes. Best Practice of Medicine. July 1999.
  5. Harrisons Principles of Internal Medicine, 13th Edition. Endocrine manifestations of neoplasia - Chapter 327 (pp. 1874-1877), Paraneoplastic neurologic syndromes - Chapter 328 (pp. 1878-1882).
  6. Cheson BD, Frame JN, Vena D, et al. Tumor lysis syndrom: An uncommon complication of fludarabine therapy of chronic lymphocytic leukemia. J Clin Oncol 1998; 16 (7): 2313-2320. Go to original source... Go to PubMed...
  7. Klener P, a kol. Klinická onkologie. Praha: Galén, 2002; 79-84.
  8. Knobel H, Loge JH, Lund MB, Fortang K, Nome O, Kaasa S. Late medical complications and fatique in Hodgkins Disease survivors. J Clin Oncol 2001; 19: 3226-3233. Go to original source... Go to PubMed...
  9. Mauldin GE. Paraneoplastic syndromes. Veterinary Oncology, 2001.
  10. Nevoralová Z. Mukokutánní paraneoplastické syndromy. http://www.lfhk.cuni.cz/dermat/verze_cz/aktuality_paraneoplasticke_syndromy_b.htm.
  11. Rizzoli R, Thiébaud D, Bundred N. et al. Serum parathyreoi hormone-related protein levels and response to bisphosphonates in hypercalcemia of malignancy. J Clin Endocrinol Metab 1999; 84 (10): 3545-3550. Go to original source... Go to PubMed...
  12. Santacroce L. Paraneoplastic syndromes. EMedicine Journal, January 2002, Vol. 3., No. 1.
  13. Yim CD, Sane SS, Bjarnason H. Superior vena cava stenting. Rdiol Clin North Am 2000; 38 (2): 409-424. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.